Lucida Medical is a UK medical technology company developing artificial intelligence to help clinicians detect prostate cancer earlier and more accurately from MRI. Its flagship solution, Pi™ (Prostate Intelligence), analyses prostate MRI scans to highlight suspicious lesions and generate risk scores that support radiologists’ decisions. CE-certified and deployed across NHS hospitals and Europe, Pi™ has been trained and validated on thousands of patient scans. Clinical research across multiple NHS Trusts has shown the system can detect clinically significant prostate cancer with performance comparable to expert radiologists.